News

Long term aspirin may reduce overall cancer risk

BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i1319 (Published 04 March 2016) Cite this as: BMJ 2016;352:i1319
  1. Jacqui Wise
  1. London

Taking low dose aspirin regularly for at least six years is associated with a modest but significant reduction in the risk of cancer, especially cancer of the gastrointestinal tract, research published in JAMA Oncology has shown.1

The study found that taking aspirin at least twice a week was associated with a 3% lower incidence of developing any type of cancer. This was primarily due to a 15% lower risk of gastrointestinal tract cancers and a 19% lower risk of cancers …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe